Itaconix PLC

Itaconix has a current ratio of 3.43, indicating strong short-term liquidity, but its operating cash flow of -$1.22 million and free cash flow of -$1.84 million suggest ongoing cash burn. The company's debt-to-equity ratio of 0.25 is relatively low, but its negative net income of -$1.38 million and operating income of -$1.24 million indicate financial stress. The company's return on equity of -16.76% and return on assets of -10.65% are significantly below the industry norms for specialty chemicals, which typically show positive returns. This underperformance is driven by high operating costs and low gross margins, with a gross profit of $3.64 million on $10.5 million in revenue. Itaconix operates as a single-segment business with all revenue derived from the sale of itaconic acid and its derivatives. There is no geographic diversification disclosed, and the company's revenue concentration is entirely within the specialty chemicals market. The company's outlook for the current fiscal year is negative, with continued losses expected. Analysts have not provided a strong buy rating, with only one buy recommendation and no strong sell ratings. The mean EPS estimate is at $0.00, compared to a last actual EPS of -$0.09. The risk assessment indicates medium liquidity risk and low dilution risk. However, the company's negative net cash position after subtracting total debt is a key flag. The dilution potential is low, and no material adjustments have been applied to the valuation metrics. Recent filings and transcripts have not disclosed any material events that would significantly alter the company's financial trajectory. The company remains in a loss-making position, and no major strategic shifts or capital-raising events have been reported in the latest available data.